Edit Content
Bizwit-Logo-Final

Bizwit Research & Consulting LLP is a global provider of business intelligence & consulting services. We have a strong primary base of key industry leaders along with the chain of industry analysts to analyze the market trends and its future impact in order to estimates and forecast different business segments and markets. 

Global Vasculitis Treatment Market to reach USD 326.80 million by the end of 2029

Global Vasculitis Treatment Market Size study & Forecast, by Drug Class (Biologics, Corticosteroids and immunosuppressants), by Disease Type (Small and medium vessel vasculitis, Large vessel vasculitis), by Distribution Channel (Hospital Pharmacies, Drug stores and retail pharmacies, Online Pharmacies) and Regional Analysis, 2022-2029

Product Code: HLSMD-72676701
Publish Date: 8-02-2023
Page: 200

Global Vasculitis Treatment Market is valued at approximately USD 250.1 million in 2021 and is anticipated to grow with a healthy growth rate of more than 3.4% over the forecast period 2022-2029. Vasculitis Treatment is a rare inflammatory disease which affects blood vessels. The inflammation causes the walls of the blood vessels to thicken, which shortens the width of the passageway through the vessel and restricts blood flow. Moreover, restricted blood flow can result in organ failure and tissue damage. There are many types of vasculitis, such as Giant cell arteritis (GCA), Takayasu’s arteritis (TAK), Aortitis, Kawasaki disease (KD), and Polyarteritis nodosa (PAN) among others. The general symptoms and signs of Vasculitis include Fever, Headache, Fatigue, Weight loss, General aches, pains, etc. The increasing vasculitis prevalence and growing incidences of chronic diseases as well as strategic initiatives from leading market players are key factors accelerating the market growth.

The increasing incidences of vasculitis prevalence are contributing towards the growth of the Global Vasculitis Treatment Market. For instance – according to Vasculitis UK – as of 2020, vasculitis affects 2000 to 3000 UK residents every year. Moreover, as per American Heart Association Journal – as of January 2021, in Sweden and Norway more than 20 new cases of GCA per 100 000 individuals aged 50 years and older are reported every year. Additionally, the lifetime risk of developing GCA is estimated at 1% for women and 0.5% for men in the United States. Also, the rapid growth of active pharmaceutical ingredient (API) industry and rising healthcare infrastructure in developing regions would create a lucrative growth prospectus for the market over the forecast period. However, side effects associated with corticosteroids and unfavorable reimbursement scenarios stifle market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Vasculitis Treatment Market study include Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the market in terms of revenue, owing to the presence of leading market players and increasing incidences of vasculitis in the region. Whereas Asia Pacific is expected to grow with the highest CAGR during the forecast period, owing to factors such as rising geriatric populations, and increasing expansion of pharmaceuticals manufacturing sector in the region.

Major market players included in this report are:
Amneal Pharmaceuticals Inc.
AstraZeneca plc
F. Hoffmann-La Roche Ltd
GlaxoSmithKline plc
Pfizer Inc.
InflaRx N.V
Novartis AG
ChemoCentryx Inc.
AbbVie Inc.
Teva Pharmaceutical Industries Ltd.

Recent Developments in the Market:
 In September 2021, Vifor Fresenius Medical Care Renal Pharma (VFMCRP) announced that Japan’s Ministry of Health and Labor Welfare (MHLW) has granted its partner, Kissei Pharmaceutical Co., Ltd., approval for marketing of TAVNEOS® for the treatment of patients with granulomatosis with polyangiitis (GPA) and microscopic polyangiitis (MPA).

 In October 2022, Amgen completed its planned acquisition of ChemoCentryx, Inc. for a transaction value of USD 3.7 billion. This acquisition also includes TAVNEOS, an orally administered inhibitor that was approved by the U.S. Food and Drug Administration (FDA) in October 2021 for the treatment of severe active ANCA-associated vasculitis.

Global Vasculitis Treatment Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Drug Class, Disease Type, Distribution Channel, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Drug Class
Biologics
Corticosteroids and immunosuppressants

By Disease Type
Small and medium vessel vasculitis
Large vessel vasculitis
By Distribution Channel
Hospital pharmacies
Drug stores and retail pharmacies
Online Pharmacies

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
RoLA
Rest of the World

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Million)
1.2.1. Vasculitis Treatment Market, by Region, 2019-2029 (USD Million)
1.2.2. Vasculitis Treatment Market, by Drug Class, 2019-2029 (USD Million)
1.2.3. Vasculitis Treatment Market, by Disease Type, 2019-2029 (USD Million)
1.2.4. Vasculitis Treatment Market, by Distribution Channel, 2019-2029 (USD Million)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Vasculitis Treatment Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Vasculitis Treatment Market Dynamics
3.1. Vasculitis Treatment Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. Increasing vasculitis prevalence
3.1.1.2. Growing incidences of chronic diseases
3.1.1.3. Strategic initiatives from leading market players
3.1.2. Market Challenges
3.1.2.1. Side effects associated with corticosteroids
3.1.2.2. Unfavourable reimbursement scenario
3.1.3. Market Opportunities
3.1.3.1. Growing active pharmaceutical ingredient (API) industry
3.1.3.2. Rising healthcare infrastructure in developing regions
Chapter 4. Global Vasculitis Treatment Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter’s 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. Industry Experts Prospective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Risk Assessment: COVID-19 Impact
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
Chapter 6. Global Vasculitis Treatment Market, by Drug Class
6.1. Market Snapshot
6.2. Global Vasculitis Treatment Market by Drug Class, Performance – Potential Analysis
6.3. Global Vasculitis Treatment Market Estimates & Forecasts by Drug Class 2019-2029 (USD Million)
6.4. Vasculitis Treatment Market, Sub Segment Analysis
6.4.1. Biologics
6.4.2. Corticosteroid
6.4.3. Immunosuppressants
Chapter 7. Global Vasculitis Treatment Market, by Disease Type
7.1. Market Snapshot
7.2. Global Vasculitis Treatment Market by Disease Type, Performance – Potential Analysis
7.3. Global Vasculitis Treatment Market Estimates & Forecasts by Disease Type 2019-2029 (USD Million)
7.4. Vasculitis Treatment Market, Sub Segment Analysis
7.4.1. Small and medium vessel vasculitis
7.4.2. Large vessel vasculitis
Chapter 8. Global Vasculitis Treatment Market, by Distribution Channel
8.1. Market Snapshot
8.2. Global Vasculitis Treatment Market by Distribution Channel, Performance – Potential Analysis
8.3. Global Vasculitis Treatment Market Estimates & Forecasts by Distribution Channel 2019-2029 (USD Million)
8.4. Vasculitis Treatment Market, Sub Segment Analysis
8.4.1. Hospital pharmacies
8.4.2. Drug store and retail pharmacies
8.4.3. Online Pharmacies
Chapter 9. Global Vasculitis Treatment Market, Regional Analysis
9.1. Vasculitis Treatment Market, Regional Market Snapshot
9.2. North America Vasculitis Treatment Market
9.2.1. U.S. Vasculitis Treatment Market
9.2.1.1. Drug Class breakdown estimates & forecasts, 2019-2029
9.2.1.2. Disease Type breakdown estimates & forecasts, 2019-2029
9.2.1.3. Distribution Channel breakdown estimates & forecasts, 2019-2029
9.2.2. Canada Vasculitis Treatment Market
9.3. Europe Vasculitis Treatment Market Snapshot
9.3.1. U.K. Vasculitis Treatment Market
9.3.2. Germany Vasculitis Treatment Market
9.3.3. France Vasculitis Treatment Market
9.3.4. Spain Vasculitis Treatment Market
9.3.5. Italy Vasculitis Treatment Market
9.3.6. Rest of Europe Vasculitis Treatment Market
9.4. Asia-Pacific Vasculitis Treatment Market Snapshot
9.4.1. China Vasculitis Treatment Market
9.4.2. India Vasculitis Treatment Market
9.4.3. Japan Vasculitis Treatment Market
9.4.4. Australia Vasculitis Treatment Market
9.4.5. South Korea Vasculitis Treatment Market
9.4.6. Rest of Asia Pacific Vasculitis Treatment Market
9.5. Latin America Vasculitis Treatment Market Snapshot
9.5.1. Brazil Vasculitis Treatment Market
9.5.2. Mexico Vasculitis Treatment Market
9.5.3. Rest of Latin America Vasculitis Treatment Market
9.6. Rest of The World Vasculitis Treatment Market

Chapter 10. Competitive Intelligence
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. Amneal Pharmaceuticals Inc.
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject to Data Availability)
10.2.1.4. Product Summary
10.2.1.5. Recent Developments
10.2.2. AstraZeneca plc
10.2.3. F. Hoffmann-La Roche Ltd
10.2.4. GlaxoSmithKline plc
10.2.5. Pfizer Inc.
10.2.6. InflaRx N.V
10.2.7. Novartis AG
10.2.8. ChemoCentryx Inc.
10.2.9. AbbVie Inc.
10.2.10. Teva Pharmaceutical Industries Ltd.
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption

At Bizwit Research and Consultancy, we employ a thorough and iterative research methodology with the goal of minimizing discrepancies, ensuring the provision of highly accurate estimates and predictions over the forecast period. Our approach involves a combination of bottom-up and top-down strategies to effectively segment and estimate quantitative aspects of the market, utilizing our proprietary data & AI tools. Our Proprietary Tools allow us for the creation of customized models specific to the research objectives. This enables us to develop tailored statistical models and forecasting algorithms to estimate market trends, future growth, or consumer behavior. The customization enhances the accuracy and relevance of the research findings.
We are dedicated to clearly communicating the purpose and objectives of each research project in the final deliverables. Our process begins by identifying the specific problem or challenge our client wishes to address, and from there, we establish precise research questions that need to be answered. To gain a comprehensive understanding of the subject matter and identify the most relevant trends and best practices, we conduct an extensive review of existing literature, industry reports, case studies, and pertinent academic research.
Critical elements of methodology employed for all our studies include:
Data Collection:
To determine the appropriate methods of data collection based on the research objectives, we consider both primary and secondary sources. Primary data collection involves gathering information directly from various industry experts in core and related fields, original equipment manufacturers (OEMs), vendors, suppliers, technology developers, alliances, and organizations. These sources encompass all segments of the value chain within the specific industry. Through in-depth interviews, we engage with key industry participants, subject-matter experts, C-level executives of major market players, industry consultants, and other relevant experts. This allows us to obtain and validate critical qualitative and quantitative information while evaluating market prospects. AI and Big Data are instrumental in our primary research, providing us with powerful tools to collect, analyze, and derive insights from data efficiently. These technologies contribute to the advancement of research methodologies, enabling us to make data-driven decisions and uncover valuable findings.
In addition to primary sources, we extensively utilize secondary sources to enhance our research. These include directories, databases, journals focusing on related industries, company newsletters, and information portals such as Bloomberg, D&B Hoovers, and Factiva. These secondary sources enable us to identify and gather valuable information for our comprehensive, technical, market-oriented, and commercial study of the market. Additionally, we utilize AI algorithms to automate the collection of vast amounts of data from various sources such as surveys, social media platforms, online transactions, and web scraping. And employ Big Data technologies for storage and processing of large datasets, ensuring that no valuable information is missed during the data collection process.
Data Analysis:
Our team of experts carefully examine the gathered data using suitable statistical techniques and qualitative analysis methods. For quantitative analysis, we employ descriptive statistics, regression analysis, and other advanced statistical methods, depending on the characteristics of the data. This analysis may also incorporate the utilization of AI tools and big data analysis techniques to extract meaningful insights.
To ensure the accuracy and reliability of our findings, we extensively leverage data science techniques, which help us minimize discrepancies and uncertainties in our analysis. We employ Data Science to clean and preprocess the data, ensuring its quality and reliability. This involves handling missing data, removing outliers, standardizing variables, and transforming data into suitable formats for analysis. The application of data science techniques enhances our accuracy, efficiency, and depth of analysis, enabling us to stay competitive in dynamic market environments.
Market Size Estimation:
Our proprietary data tools play a crucial role in deriving our market estimates and forecasts. Each study involves the creation of a unique and customized model. The model incorporates the gathered information on market dynamics, technology landscape, application development, and pricing trends. AI techniques, such as machine learning and deep learning, aid us to analyze patterns within the data to identify correlations, trends, and relationships. By recognizing patterns in consumer behavior, purchasing habits, or market dynamics, our AI algorithms aid us in more precise estimations of market size. These factors are simultaneously analyzed within the model, allowing for a comprehensive assessment. To quantify their impact over the forecast period, correlation, regression, and time series analysis are employed.
To estimate and validate the market size, we employ both top-down and bottom-up approaches. The preference is given to a bottom-up approach, where key regional markets are analyzed as separate entities. This data is then integrated to obtain global estimates. This approach is crucial as it provides a deep understanding of the industry and helps minimize errors.
In our forecasting process, we consider various parameters such as economic tools, technological analysis, industry experience, and domain expertise. By taking all these factors into account, we strive to produce accurate and reliable market forecasts. When forecasting, we take into consideration several parameters, which include:
Market driving trends and favorable economic conditions
Restraints and challenges that are expected to be encountered during the forecast period.
Anticipated opportunities for growth and development
Technological advancements and projected developments in the market
Consumer spending trends and dynamics
Shifts in consumer preferences and behaviors.
The current state of raw materials and trends in supply versus pricing
Regulatory landscape and expected changes or developments.
The existing capacity in the market and any expected additions or expansions up to the end of the forecast period.
To assess the market impact of these parameters, we assign weights to each one and utilize weighted average analysis. This process allows us to quantify their influence on the market and derive an expected growth rate for the forecasted period. By considering these various factors and applying a weighted analysis approach, we strive to provide accurate and reliable market forecasts.
Insight Generation & Report Presentation:
After conducting the research, our experts analyze the findings in relation to the research objectives and the specific needs of the client. They generate valuable insights and recommendations that directly address the client’s business challenges. These insights are carefully connected to the research findings to provide a comprehensive understanding.
Next, we create a well-structured research report that effectively communicates the research findings, insights, and recommendations to the client. To enhance clarity and comprehension, we utilize visual aids such as charts, graphs, and tables. These visual elements are employed to present the data in an engaging and easily understandable format, ensuring that the information is accessible and visually appealing to the client. Our aim is to deliver a clear and concise report that conveys the research findings effectively and provides actionable recommendations to meet the client’s specific needs.

Need Assistance

Contact Person -
Krishant Mennon
Call us @
+ 91 99931 15879
Email: sales@bizwitresearch.com

Checkout

Why Choose Us?

Quality over Quantity

Backed by 60+ paid data sources our reports deliver crisp insights with no compromise quality.

Analyst Support

24x7 Chat Support plus
free analyst hours with every purchase

Flawless Methodology

Our 360-degree approach of market study, our research methods leave stones unturned.

Enquiry Now